The progression of prostate cancer from an androgen-dependent state to an androgen-independent state is a critical step in the development of advanced disease, and recent studies have shown that this transition is mediated by the activation of various growth factor signaling pathways, including the PI3K/Akt/mTOR pathway [3]. Here, AKT1 is linked to prostate cancer.